One dead after legionnaires' outbreak
NSW Health said 12 people who spent time in the city and surrounding suburbs between March and April had contracted the deadly disease.
'Sadly, one of the people who contracted the disease passed away in hospital last week,' a NSW Health spokesman said on Wednesday.
Authorities tested more than 165 cooling towers in the city and detected legionella bacteria in one.
The cooling tower is being decontaminated and further tests are being conducted to determine if it was the source of the outbreak.
Anyone who was in the Sydney CBD and surrounding suburbs between March and April is urged to be aware of symptoms including fever, chills, coughing and shortness of breath.
Symptoms can develop up to 10 days after exposure and anyone who experiences symptoms should see their doctor.
South Eastern Sydney Local Heath District Public Health Unit Director Vicky Sheppeard said 11 people with the disease had been hospitalised and one person received care out of hospital.
'Legionnaires' disease is caused by infection with legionella bacteria,' Dr Sheppeard said.
'Outbreaks sometimes occur when bacteria from environmental sources such as cooling towers atop large buildings become contaminated. It is not spread from person to person.
'NSW Health continues to work closely with the City of Sydney to identify, inspect and sample any cooling towers in the CBD potentially implicated in the outbreak.
'Most building owners have responded quickly to ensure that their cooling towers are operated and maintained in compliance with the NSW Public Health Regulation 2022.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
14 minutes ago
- Yahoo
Map shows more than 1,300 measles cases across U.S.
In 2025, the United States has recorded the most measles cases in more than 30 years, Centers for Disease Control and Prevention data shows. A large share of the infections were connected to an outbreak in West Texas that led to the deaths of two children. The number of cases in Texas alone grew to over 760 before the state declared it officially over in August, while total cases nationwide have topped 1,300, with infections confirmed in at least 39 states. Measles is one of the most contagious infectious diseases, and in some cases, can cause severe infections in the lungs and brain that can lead to cognitive issues, deafness or death. But doctors and health officials say the vaccine, which is normally given as part of the combination measles-mumps-rubella (MMR) vaccine, is highly safe and effective. While most people's symptoms improve, about 1 in 5 unvaccinated people who get measles will be hospitalized. About 1 out of every 1,000 children with measles will develop brain swelling that can lead to brain damage, and up to 3 of every 1,000 children who become infected will die, the CDC says. The largest outbreak so far this year has been in West Texas, but cases have been reported in other states around the country, as well. The CBS News data team is tracking confirmed measles cases nationwide as new data is released by state health departments and the CDC. (The map below is updated on Wednesdays when the CDC releases its latest weekly numbers.) The Texas outbreak primarily affected children and teenagers, nearly all of whom were unvaccinated or had an unknown vaccination status. State and local health officials confirmed the first patient who died was an unvaccinated school-aged child, and the second was an unvaccinated 8-year-old girl. Neither of the children had underlying health conditions, the Texas health department said. New Mexico also reported the death of an adult with measles. The last measles death in the U.S. before this year was in 2019, when a 37-year-old man died from measles complicated by meningitis in California, according to CDC data. Until now, the highest number of confirmed cases in the U.S. in recent years was 1,274 in 2019, driven by outbreaks in New York, California and Washington state, but most years the total has been much lower. Health experts point to lower vaccination rates as a reason for increases in preventable diseases like the measles. CDC data shows about 93% of kindergarteners in the U.S. were vaccinated against measles during the 2021-2022 school year and only 92.7% in the 2023-2024 school year. This is down from 95.2% during the 2019-2020 school year — a critical threshold to keep people safe. "When more than 95% of people in a community are vaccinated, most people are protected through community immunity (herd immunity)," the CDC states. Health and Human Services Secretary Robert F. Kennedy Jr., who has a history of making false and misleading claims about vaccines, voiced support for vaccination as the deadly outbreak spread in the Southwest. "We encourage people to get the measles vaccine," Kennedy told CBS News chief medical correspondent Dr. Jon LaPook in an interview April 8, marking the first time Kennedy has publicly urged people to get the measles vaccine since becoming HHS secretary. Asked by LaPook what the federal government's official position on the vaccine is, Kennedy reiterated, "The federal government's position, my position, is that people should get the measles vaccine," but added, "The government should not be mandating those." Alaska Sen. Dan Sullivan on the Trump-Putin summit, sanctions and more A robotics activist's remarkable crusade A look at Taylor Swift's marketing strategy as upcoming album makes new headlines Solve the daily Crossword
Yahoo
2 hours ago
- Yahoo
CSL slashes 15% of workforce and offshoots vaccine division
Australia's largest pharmaceutical company CSL will reduce its headcount by 15% and spin off its vaccine division in response to an 'unprecedented level of challenge and volatility'. CSL expects a one-off, pre-tax restructuring cost hit of $700m-$770m in the 2026 financial year. The company has conducted a series of changes across its research & development (R&D) department, operating model, and plasma network. For example, the company closed 22 underperforming plasma centres in August 2025. CSL did not disclose the areas of the company from where the 15% reduction in employee base would be initiated. As of 2024, CSL employs 32,000 people globally. The initiatives are expected to lead to savings of $500m-$550m progressively over the next three years, with the majority achieved by the end of the 2027 financial year. CSL said it would redirect the funds to 'high priority opportunities'. While most of CSL's revenue comes from its blood plasma treatments for rare illnesses, the pharma company is also one of the world's largest influenza vaccine manufacturers. It supplies more than 130 million doses of seasonal influenza doses globally each year in its Afluria, Fluad and Flucelvax brands. CSL also announced a planned spin-off of its vaccine division, known as CSL Seqirus. The company did not disclose a valuation for the demerger, which is slated to be completed in early 2026 and produce a publicly listed company in Australia, but CEO Dr Paul McKenzie said it would help 'reshape and simplify the [core] business'. Profit in the vaccine unit dipped due to reduced demand in the US – a revenue area the company hopes to address in 2026. "We firmly believe that a simplified and focused CSL is best for patients, best for our people, and best for our shareholders,' McKenzie added. The company said it would also buy back A$750m ($486.50m) of shares this financial year, partaking in a wider trend of share buybacks across the global pharma industry. Sanofi and Eli Lilly are both undertaking billion-dollar share buyback programmes. The significant restructuring, announced on CSL's 2025 financial year earnings report, eclipsed what was a positive year for the company. Net profit after tax was $3bn for the past 12 months up to June 2025, a rise of 15% on constant currencies. CSL's headcount reduction and vaccine spinoff dragged shares down 9.5%, from A$271.32 at market close on 18 August to A$245.45 at market open on 19 August. The Australian-listed company has a market cap of A$109.1bn, making it the country's fifth-largest company. In regard to impacts from tariffs, McKenzie said CSL's strategic initiatives would not be impacted due to its heavy US manufacturing presence. His statement echoed wider sentiment shared by big pharma company execs in the Q2 earnings window, many of whom expect minimal impact. Navigate the shifting tariff landscape with real-time data and market-leading analysis. Request a free demo for GlobalData's Strategic Intelligence . "CSL slashes 15% of workforce and offshoots vaccine division" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
New York Post
3 hours ago
- New York Post
Fifth New Yorker dies from Legionnaires disease outbreak in Harlem as cases rise to 108 sickened
A fifth New Yorker has died in the Legionnaires' disease outbreak in Harlem, city health officials said. The cluster of the pneumonia-like illness, first detected on July 25, has spread across five zip codes in Upper Manhattan and sickened at least 108 people — including 14 who are currently hospitalized, according to a Monday update from the New York City Health Department. The death toll rose just as city officials announced Friday that 12 cooling towers in Central Harlem that tested positive for live Legionella bacteria have been fully drained, cleaned, and disinfected. Advertisement 3 The rising death toll came as city officials confirmed Friday that 12 Central Harlem cooling towers testing positive for live Legionella bacteria have now been fully drained, cleaned, and disinfected. Luiz C. Ribeiro for New York Post So far, the disease has been detected in zip codes 10027, 10030, 10035, 10037 and 10039, as well as in neighboring communities. 3 Cases have so far been reported in zip codes 10027, 10030, 10035, 10037, and 10039, along with nearby neighborhoods. Rob Jejenich / NY Post Design Advertisement While deadly if not treated in time, Legionnaires' disease is easily curable with antibiotics if caught early, officials said. The health department has urged those who live or work in the area and are experiencing flu-like symptoms to see a health care provider right away. 3 The health department has urged those who live or work in the area and are experiencing flu-like symptoms to see a health care provider right away. Google Earth Symptoms of the disease, which cannot be spread from person to person, include cough, fever, chills, muscle aches, and shortness of breath.
